BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26675716)

  • 1. Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors.
    Sheffield KS; Vohra R; Scott JA; Ross GM
    Pharmacol Res; 2016 Jan; 103():292-9. PubMed ID: 26675716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy.
    Sheffield KS; Kennedy AE; Scott JA; Ross GM
    Anal Biochem; 2016 Jan; 493():21-6. PubMed ID: 26435172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
    Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
    J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF ligand alters NGF signaling via p75(NTR) and trkA.
    Niederhauser O; Mangold M; Schubenel R; Kusznir EA; Schmidt D; Hertel C
    J Neurosci Res; 2000 Aug; 61(3):263-72. PubMed ID: 10900073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].
    Al-Gayyar MM; Matragoon S; Pillai BA; Ali TK; Abdelsaid MA; El-Remessy AB
    Diabetologia; 2011 Mar; 54(3):669-80. PubMed ID: 21136036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease-associated globotriaosylceramide induces mechanical allodynia via activation of signaling through proNGF-p75
    Sugimoto J; Satoyoshi H; Takahata K; Muraoka S
    Eur J Pharmacol; 2021 Mar; 895():173882. PubMed ID: 33482180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of proNGF or its receptor p75
    Mossa AH; Galan A; Cammisotto PG; Velasquez Flores M; Shamout S; Barcelona P; Saragovi HU; Campeau L
    Diabetologia; 2020 Sep; 63(9):1932-1946. PubMed ID: 32699962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.
    Barcelona PF; Saragovi HU
    Mol Cell Biol; 2015 Oct; 35(19):3396-408. PubMed ID: 26217017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro.
    Eibl JK; Strasser BC; Ross GM
    Eur J Pharmacol; 2013 May; 708(1-3):30-7. PubMed ID: 23528360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of pro-nerve growth factor, neurotrophin receptor p75, and sortilin is associated with retrovirus-induced spongiform encephalomyelopathy.
    Stoica G; Lungu G; Kim HT; Wong PK
    Brain Res; 2008 May; 1208():204-16. PubMed ID: 18395188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor (NGF)-mediated regulation of p75(NTR) expression contributes to chemotherapeutic resistance in triple negative breast cancer cells.
    Chakravarthy R; Mnich K; Gorman AM
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1541-7. PubMed ID: 27577679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
    Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis.
    Kendall TJ; Hennedige S; Aucott RL; Hartland SN; Vernon MA; Benyon RC; Iredale JP
    Hepatology; 2009 Mar; 49(3):901-10. PubMed ID: 19072833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.
    Mysona BA; Al-Gayyar MM; Matragoon S; Abdelsaid MA; El-Azab MF; Saragovi HU; El-Remessy AB
    Diabetologia; 2013 Oct; 56(10):2329-39. PubMed ID: 23918145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses of PC12 cells to different pro-nerve growth factor protein variants.
    Soligo M; Albini M; Bertoli FL; Marzano V; Protto V; Bracci-Laudiero L; Minnone G; De Benedetti F; Chiaretti A; Mantuano E; Manni L
    Neurochem Int; 2019 Oct; 129():104498. PubMed ID: 31278975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin.
    Clewes O; Fahey MS; Tyler SJ; Watson JJ; Seok H; Catania C; Cho K; Dawbarn D; Allen SJ
    J Neurochem; 2008 Nov; 107(4):1124-35. PubMed ID: 18808449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-Nerve Growth Factor Induces Activation of RhoA Kinase and Neuronal Cell Death.
    Sycheva M; Sustarich J; Zhang Y; Selvaraju V; Geetha T; Gearing M; Babu JR
    Brain Sci; 2019 Aug; 9(8):. PubMed ID: 31430874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic structural disorder of mouse proNGF.
    Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
    Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swedish Nerve Growth Factor Mutation (NGF
    Sung K; Ferrari LF; Yang W; Chung C; Zhao X; Gu Y; Lin S; Zhang K; Cui B; Pearn ML; Maloney MT; Mobley WC; Levine JD; Wu C
    J Neurosci; 2018 Apr; 38(14):3394-3413. PubMed ID: 29483280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p75(NTR) expression reduces nerve growth factor immunolocalization in cholinergic septal neurons.
    Krol KM; Crutcher KA; Kalisch BE; Rylett RJ; Kawaja MD
    J Comp Neurol; 2000 Nov; 427(1):54-66. PubMed ID: 11042591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.